Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial

Background: The elderly (>= 75 years) constitute a high-risk subset of patients who continue to have a poorer prognosis than non-elderly (= 75 years was an independent predictor of POCE (HR 2.19 [95% CI 1.59-3.01], p < 0.0001) and DOCE (HR 2.42 [95% CI 1.60-3.7], p < 0.001) at 1-year. Conclusions: In STEMI patients undergoing PPCI, advanced age (>= 75 years) is associated with worse outcomes. The beneficial effects of EES over BMS tended to be age-dependent. (C) 2014 Elsevier Ireland Ltd. All rights reserved.